Physician profile
Brian J Oneil
NPI 1710948914
$11,431.93
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,057 · 2020: $1,319 · 2021: $159 · 2022: $2,313 · 2023: $505 · 2024: $78.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $400 · Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $400.00 |
| Food and Beverage | $183.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Circulation INC | $5,618.64 | 2019-2022 | |
| Brainscope Company, INC. | $1,849.93 | 2019 | |
| Abbott Laboratories | $1,636.00 | 2021-2022 | |
| Roche Diagnostics Corporation | $1,200.00 | 2020 | |
| Quidel Corporation | $400.00 | 2023 | |
| Janssen Pharmaceuticals, INC | $300.85 | 2019-2020 | |
| Angiodynamics, INC. | $166.29 | 2023-2024 | Angiovac, Alphavac |
| Genentech USA, INC. | $102.56 | 2019 | |
| Zoll Medical Corporation | $80.62 | 2022 | |
| Pfizer INC. | $59.92 | 2019 | |
| Resmed Corp | $17.12 | 2024 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Oneil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.